http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007060012-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5fe2464f092ecee7f729b04eb5f912f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-08 |
| filingDate | 2006-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d80f2ab0cf0d47470434dd152ae3bd58 |
| publicationDate | 2007-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2007060012-A3 |
| titleOfInvention | Use of l-phenylalanine conjugated to an emitting isotope for therapy of hormone dependent carcinoma |
| abstract | The present invention provides a use of a L-phenylalanine conjugated to an alpha-, beta- or Auger-electron emitting isotope selected from the group consisting of bromine-76, bromine-77, bromine-82, iodine-124, iodine-125, iodine-131 and astatine-211 for the preparation of a pharmaceutical composition for the treatment of hormone dependent carcinoma and hormone-refractory or metastasized carcinoma derived from hormone dependent carcinoma. Furthermore, the invention provides an according method for the treatment of hormone dependent carcinoma and hormone-refractory or metastasized carcinoma derived from hormone dependent carcinoma and a method for the monitoring of the progress of such treatment. |
| priorityDate | 2005-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.